Results for 'CRISPR Therapeutics' Create an alert

CRISPR Therapeutics says it’s ready to test a CRISPR-based therapy on people.
CRISPR Therapeutics' stock is tumbling after a report that edited genes might cause cancer.
Last week, Crispr Therapeutics announced it has asked regulators in Europe for permission to trial a cure for the disease beta thalassemia
FDA slaps a clinical hold on sickle cell IND filed by Vertex and CRISPR Therapeutics
$VRTX $CRSP -20%
BREAKING: CRISPR Therapeutics, which aims to use gene editing to treat disease, is planning a $90 million IPO:
Coming soon: #CRISPR’s clinical debut. Vertex Pharmaceuticals and CRISPR Therapeutics will begin the first human studies of a CRISPR therapy in the U.S. and Europe next year.
Total(1) => 0.065229892730713 f_f_QM(2) => 0.052536010742188 indS(2) => 0.017014026641846 indM(2) => 0.035398721694946 indM_1(2) => 0.0048022270202637 indM_2(2) => 0.0015568733215332 indM_4(2) => 0.0028748512268066 indM_5(2) => 0.006411075592041 indM_6(2) => 0.0024569034576416 indM_7(2) => 0.0039560794830322 indM_8(2) => 0.0010702610015869 f_f_pTL(2) => 0.0042479038238525 f_f_dT(16) => 0.0040137767791748